Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2003
Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signalingSylvie Rodrigues, Elisabeth Van Aken, Saskia Van Bocxlaer, et al.
European Journal of Pharmacology|November 16, 2010
Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cellsSamir Attoub, Ahmed H Hassan, Barbara Vanhoecke, et al.
Cancers|June 22, 2023
Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer CellsAysha Alneyadi, Zohra Nausheen Nizami, Hanan E Aburawi, et al.
Frontiers in Oncology|September 1, 2017
The IL-6/STAT3 Signaling Pathway Is an Early Target of Manuka Honey-Induced Suppression of Human Breast Cancer CellsPriyanka Aryappalli, Sarah S Al-Qubaisi, Samir Attoub, et al.
International Journal of Molecular Sciences|September 8, 2019
Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 ReceptorPriyanka Aryappalli, Khadija Shabbiri, Razan J Masad, et al.
Cancer Research|January 25, 2005
Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -- and vascular endothelial growth factor-mediated cellular invasion and tumor growthChristine Rivat, Rivat Christine, Sylvie Rodrigues, et al.
Cancer Research|September 20, 2006
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complexGrégoire P Prévost, Marie O Lonchampt, Susan Holbeck, et al.
Molecular Biomedicine|May 11, 2026
Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J proteinMaram Ahmed, Shoja M Haneefa, Aftab Alam, et al.
Scientific Reports|September 28, 2020
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasisLucy Kappes, Ruba L Amer, Sabine Sommerlatte, et al.
Pageof 8